Amylyx Pharmaceuticals, Inc. Common Stock (AMLX)
Market Closed
1 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
33. 81
+0.06
+0.1778%
$
3.75B Market Cap
- P/E Ratio
- Div Yield
1.82M Volume
- Eps
$ 33.75
Previous Close 
Want to track AMLX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Amylyx to buy bankrupt Eiger's experimental drug to treat low blood sugar
Amylyx Pharmaceuticals has agreed to buy the rights to bankrupt drugmaker Eiger BioPharmaceuticals' experimental drug for low blood sugar in a $35.1 million deal, Eiger said in a filing on Friday.
Reuters | 2 years ago
